+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Antimalarial Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028: Segmented By Drug Type, By Drug Class, By Route of Administration, By Malaria Type, By Application, By Distribution Channel, By Region, Forecast & Opportunities, 2028

  • PDF Icon

    Report

  • 115 Pages
  • December 2022
  • Region: Global
  • TechSci Research
  • ID: 5706799
Free Webex Call
10% Free customization
Description Jump to:

Increasing prevalence of malaria coupled with surge in research for new antimalarial drugs is anticipated to propel the growth of the market

Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

 10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.
Global antimalarial drugs market is expected to register impressive growth during the forecast period, 2024-2028. Increasing prevalence of malaria coupled with surge in research for new antimalarial drugs is anticipated to propel the growth of the market. According to the “World Malaria Report 2021” by World Health Organization (WHO), in 2020, there were approximately 228 million cases and about 6,02,000 malaria-related deaths. Moreover, the increase in awareness initiatives by governments is also a key factor for growth of antimalarial drugs market. In 2021, the government of Malawi launched a 'Zero Malaria Starts with Me' campaign to stop malaria by the year 2030, which is the leading cause of death in Malawi.

Additionally, rise in malaria death cases, especially in developing nations are also fueling the growth of antimalarial drugs market. According to World Health Organization (WHO), about half of the world's population is at risk of malaria.

Global antimalarial drugs market can be segmented based on drug type, drug class, route of administration, malaria type, application, distribution channel, company, and region. Based on drug class, the market is segmented into aryl aminoalcohol compounds, antifolate compounds, artemisinin compounds and antimicrobials. Among them, the aryl aminoalcohol compounds segment is expected to witness high growth during the forecast period owing to rising cases of malaria across the world.

Based on route of administration, the global antimalarial drugs market is segmented into oral, powder inhalation and intravenous administration. Among them, the oral segment is expected to undergo high growth through 2028 owing to the advantages such as safety, easy ingestion, pain avoidance and better patient compliance.

Major companies operating in global antimalarial drugs market include Cipla Ltd, GlaxoSmithKline Plc, Ipca Laboratories Ltd., Merck & Co., Inc, Novartis AG, Zydus Cadila, Sun Pharmaceutical Industries Ltd. (Ranbaxy Laboratories), Strides Pharma Science Limited, Glenmark Pharmaceuticals Ltd., and Lincoln Pharmaceuticals Ltd. The market players are adopting growth strategies like new product launches, mergers & partnerships to increase their global market share.

Objective of the Study:

To analyze and forecast the market size of global antimalarial drugs market.

To forecast global antimalarial drugs market based on drug type, drug class, route of administration, malaria type, application, distribution channel, company and regional distribution.

To identify drivers and challenges for global antimalarial drugs market.

To examine competitive developments such as expansions, new product launches, mergers & acquisitions etc. in global antimalarial drugs market.

To identify and analyse the profile of leading players operating in the global antimalarial drugs market.

The publisher performed both primary as well as exhaustive secondary research for this study. Initially, The research team sourced a list of antimalarial drugs companies across the globe. Subsequently, The research team conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, the publisher could include the companies which could not be identified due to the limitations of secondary research.

The publisher calculated global antimalarial drugs market size using a bottom-up approach, where data for various end user industries and its application across various product types were recorded and forecast for the future years. The research team sourced these values from the industry experts and company representatives and externally validated through analysing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also used.

Key Target Audience:

  • Antimalarial drugs companies/partners, investors, and other stakeholders

Hospital pharmacy/ retail pharmacy

  • Government bodies such as regulating authorities and policy makers
  • Organizations, industry associations, forums and alliances related to antimalarial drugs

Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as antimalarial drugs vendors, end users etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global antimalarial drugs market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Global Antimalarial Drugs Market, By Drug Type:

  • Quinine
  • Chloroquine
  • Proguanil
  • Amodiaquine
  • Mefloquine
  • Hydroxychloroquine
  • Pyrimethamine
  • Others

Global Antimalarial Drugs Market, By Drug Class:

  • Aryl Aminoalcohol Compounds
  • Antifolate Compounds
  • Artemisinin Compounds
  • Antimicrobials

Global Antimalarial Drugs Market, By Route of Administration:

  • Oral
  • Powder Inhalation
  • Intravenous Administration

Global Antimalarial Drugs Market, By Malaria Type:

  • Plasmodium Falciparum
  • Plasmodium Malariae
  • Plasmodium Vivax
  • Plasmodium Ovale
  • Plasmodium Knowlesi

Global Antimalarial Drugs Market, By Application:

  • Prevention
  • Treatment of Malaria

Global Antimalarial Drugs Market, By Distribution Channel:

  • Hospital Pharmacy
  • Retail Pharmacy
  • E-Commerce
  • Others

Global Antimalarial Drugs Market, By Region:

  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Singapore
  • Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain
  • North America
  • United States
  • Mexico
  • Canada
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global antimalarial drugs market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Profit Margin Analysis

Profit margin analysis in case of direct and indirect sales channel.


This product will be delivered within 1-3 business days.

Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Clinical Trial Analysis
5.1. Ongoing Clinical Trials
5.2. Completed Clinical Trials
5.3. Terminated Clinical Trials
5.4. Breakdown of Pipeline, By Development Phase
5.5. Breakdown of Pipeline, By Status
5.6. Breakdown of Pipeline, By Study Type
5.7. Breakdown of Pipeline, By Country
5.8. Clinical Trials Heat Map
6. Global Antimalarial Drugs Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value & Volume
6.2. Market Share & Forecast
6.2.1. By Drug Type (Quinine, Chloroquine, Proguanil, Amodiaquine, Mefloquine, Hydroxychloroquine, Pyrimethamine, Others)
6.2.2. By Drug Class (Aryl Aminoalcohol Compounds, Antifolate Compounds, Artemisinin Compounds, Antimicrobials)
6.2.3. By Route of Administration (Oral, Powder Inhalation, Intravenous Administration)
6.2.4. By Malaria Type (Plasmodium Falciparum, Plasmodium Malariae, Plasmodium Vivax, Plasmodium Ovale, Plasmodium Knowlesi)
6.2.5. By Application (Prevention, Treatment of Malaria)
6.2.6. By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, E-Commerce, Others)
6.2.7. By Company (2022)
6.2.8. By Region
6.3. Product Market Map
7. Asia-Pacific Antimalarial Drugs Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value & Volume
7.2. Market Share & Forecast
7.2.1. By Drug Type
7.2.2. By Drug Class
7.2.3. By Route of Administration
7.2.4. By Malaria Type
7.2.5. By Application
7.2.6. By Distribution Channel
7.2.7. By Country
7.3. Asia-Pacific: Country Analysis
7.3.1. China Antimalarial Drugs Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value & Volume
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Drug Type
7.3.1.2.2. By Drug Class
7.3.1.2.3. By Route of Administration
7.3.1.2.4. By Malaria Type
7.3.1.2.5. By Application
7.3.1.2.6. By Distribution Channel
7.3.2. India Antimalarial Drugs Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value & Volume
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Drug Type
7.3.2.2.2. By Drug Class
7.3.2.2.3. By Route of Administration
7.3.2.2.4. By Malaria Type
7.3.2.2.5. By Application
7.3.2.2.6. By Distribution Channel
7.3.3. Japan Antimalarial Drugs Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value & Volume
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Drug Type
7.3.3.2.2. By Drug Class
7.3.3.2.3. By Route of Administration
7.3.3.2.4. By Malaria Type
7.3.3.2.5. By Application
7.3.3.2.6. By Distribution Channel
7.3.4. South Korea Antimalarial Drugs Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value & Volume
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Drug Type
7.3.4.2.2. By Drug Class
7.3.4.2.3. By Route of Administration
7.3.4.2.4. By Malaria Type
7.3.4.2.5. By Application
7.3.4.2.6. By Distribution Channel
7.3.5. Singapore Antimalarial Drugs Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value & Volume
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Drug Type
7.3.5.2.2. By Drug Class
7.3.5.2.3. By Route of Administration
7.3.5.2.4. By Malaria Type
7.3.5.2.5. By Application
7.3.5.2.6. By Distribution Channel
7.3.6. Australia Antimalarial Drugs Market Outlook
7.3.6.1. Market Size & Forecast
7.3.6.1.1. By Value & Volume
7.3.6.2. Market Share & Forecast
7.3.6.2.1. By Drug Type
7.3.6.2.2. By Drug Class
7.3.6.2.3. By Route of Administration
7.3.6.2.4. By Malaria Type
7.3.6.2.5. By Application
7.3.6.2.6. By Distribution Channel
8. Europe Antimalarial Drugs Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value & Volume
8.2. Market Share & Forecast
8.2.1. By Drug Type
8.2.2. By Drug Class
8.2.3. By Route of Administration
8.2.4. By Malaria Type
8.2.5. By Application
8.2.6. By Distribution Channel
8.2.7. By Country
8.3. Europe: Country Analysis
8.3.1. France Antimalarial Drugs Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value & Volume
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Drug Type
8.3.1.2.2. By Drug Class
8.3.1.2.3. By Route of Administration
8.3.1.2.4. By Malaria Type
8.3.1.2.5. By Application
8.3.1.2.6. By Distribution Channel
8.3.2. Germany Antimalarial Drugs Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value & Volume
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Drug Type
8.3.2.2.2. By Drug Class
8.3.2.2.3. By Route of Administration
8.3.2.2.4. By Malaria Type
8.3.2.2.5. By Application
8.3.2.2.6. By Distribution Channel
8.3.3. United Kingdom Antimalarial Drugs Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value & Volume
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Drug Type
8.3.3.2.2. By Drug Class
8.3.3.2.3. By Route of Administration
8.3.3.2.4. By Malaria Type
8.3.3.2.5. By Application
8.3.3.2.6. By Distribution Channel
8.3.4. Italy Antimalarial Drugs Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value & Volume
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Drug Type
8.3.4.2.2. By Drug Class
8.3.4.2.3. By Route of Administration
8.3.4.2.4. By Malaria Type
8.3.4.2.5. By Application
8.3.4.2.6. By Distribution Channel
8.3.5. Spain Antimalarial Drugs Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value & Volume
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Drug Type
8.3.5.2.2. By Drug Class
8.3.5.2.3. By Route of Administration
8.3.5.2.4. By Malaria Type
8.3.5.2.5. By Application
8.3.5.2.6. By Distribution Channel
9. North America Antimalarial Drugs Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value & Volume
9.2. Market Share & Forecast
9.2.1. By Drug Type
9.2.2. By Drug Class
9.2.3. By Route of Administration
9.2.4. By Malaria Type
9.2.5. By Application
9.2.6. By Distribution Channel
9.2.7. By Country
9.3. North America: Country Analysis
9.3.1. United States Antimalarial Drugs Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value & Volume
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Drug Type
9.3.1.2.2. By Drug Class
9.3.1.2.3. By Route of Administration
9.3.1.2.4. By Malaria Type
9.3.1.2.5. By Application
9.3.1.2.6. By Distribution Channel
9.3.2. Mexico Antimalarial Drugs Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value & Volume
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Drug Type
9.3.2.2.2. By Drug Class
9.3.2.2.3. By Route of Administration
9.3.2.2.4. By Malaria Type
9.3.2.2.5. By Application
9.3.2.2.6. By Distribution Channel
9.3.3. Canada Antimalarial Drugs Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value & Volume
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Drug Type
9.3.3.2.2. By Drug Class
9.3.3.2.3. By Route of Administration
9.3.3.2.4. By Malaria Type
9.3.3.2.5. By Application
9.3.3.2.6. By Distribution Channel
10. South America Antimalarial Drugs Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value & Volume
10.2. Market Share & Forecast
10.2.1. By Drug Type
10.2.2. By Drug Class
10.2.3. By Route of Administration
10.2.4. By Malaria Type
10.2.5. By Application
10.2.6. By Distribution Channel
10.2.7. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Antimalarial Drugs Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value & Volume
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Drug Type
10.3.1.2.2. By Drug Class
10.3.1.2.3. By Route of Administration
10.3.1.2.4. By Malaria Type
10.3.1.2.5. By Application
10.3.1.2.6. By Distribution Channel
10.3.2. Argentina Antimalarial Drugs Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value & Volume
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Drug Type
10.3.2.2.2. By Drug Class
10.3.2.2.3. By Route of Administration
10.3.2.2.4. By Malaria Type
10.3.2.2.5. By Application
10.3.2.2.6. By Distribution Channel
10.3.3. Colombia Antimalarial Drugs Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value & Volume
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Drug Type
10.3.3.2.2. By Drug Class
10.3.3.2.3. By Route of Administration
10.3.3.2.4. By Malaria Type
10.3.3.2.5. By Application
10.3.3.2.6. By Distribution Channel
11. Middle East and Africa Antimalarial Drugs Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value & Volume
11.2. Market Share & Forecast
11.2.1. By Drug Type
11.2.2. By Drug Class
11.2.3. By Route of Administration
11.2.4. By Malaria Type
11.2.5. By Application
11.2.6. By Distribution Channel
11.2.7. By Country
11.3. MEA: Country Analysis
11.3.1. South Africa Antimalarial Drugs Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value & Volume
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Drug Type
11.3.1.2.2. By Drug Class
11.3.1.2.3. By Route of Administration
11.3.1.2.4. By Malaria Type
11.3.1.2.5. By Application
11.3.1.2.6. By Distribution Channel
11.3.2. Saudi Arabia Antimalarial Drugs Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value & Volume
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Drug Type
11.3.2.2.2. By Drug Class
11.3.2.2.3. By Route of Administration
11.3.2.2.4. By Malaria Type
11.3.2.2.5. By Application
11.3.2.2.6. By Distribution Channel
11.3.3. UAE Antimalarial Drugs Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value & Volume
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Drug Type
11.3.3.2.2. By Drug Class
11.3.3.2.3. By Route of Administration
11.3.3.2.4. By Malaria Type
11.3.3.2.5. By Application
11.3.3.2.6. By Distribution Channel
12. Market Dynamics
12.1. Drivers
12.2. Challenges
13. Market Trends & Developments
14. Competitive Landscape
14.1. Competition Outlook
14.2. Players Profiled (Leading Companies)
14.2.1. Cipla Ltd
14.2.2. GlaxoSmithKline Plc
14.2.3. Ipca Laboratories Ltd.
14.2.4. Merck & Co., Inc
14.2.5. Novartis AG
14.2.6. Zydus Cadila
14.2.7. Sun Pharmaceutical Industries Ltd. (Ranbaxy Laboratories)
14.2.8. Strides Pharma Science Limited
14.2.9. Glenmark Pharmaceuticals Ltd.
14.2.10. Lincoln Pharmaceuticals Ltd.
15. Strategic Recommendations

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Cipla Ltd
  • GlaxoSmithKline Plc
  • Ipca Laboratories Ltd.
  • Merck & Co., Inc
  • Novartis AG
  • Zydus Cadila
  • Sun Pharmaceutical Industries Ltd. (Ranbaxy Laboratories)
  • Strides Pharma Science Limited
  • Glenmark Pharmaceuticals Ltd.
  • Lincoln Pharmaceuticals Ltd.

Related Topics

Related Reports

Antimalarial Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2030 - (By Drug Class Coverage, Route of Administration Coverage, Distribution Channel Coverage, Geographic Coverage and Leading Companies) - Product Image

Antimalarial Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2030 - (By Drug Class Coverage, Route of Administration Coverage, Distribution Channel Coverage, Geographic Coverage and Leading Companies)

  • Report
  • 185 Pages
  • Global
Antimalarial Medication Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Antimalarial Medication Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 104 Pages
  • Global
From
Systemic Lupus Erythematosus (SLE) Drugs Market by Drug Class (Antimalarials Drugs, Non-Steroidal Anti-Inflammatory Drugs (NSAIDS), Cytotoxic and Immunosuppressive Drugs, Biologics, and Others), Mode of Delivery (Intravenous, Subcutaneous, Oral), and Region 2024-2032 - Product Image

Systemic Lupus Erythematosus (SLE) Drugs Market by Drug Class (Antimalarials Drugs, Non-Steroidal Anti-Inflammatory Drugs (NSAIDS), Cytotoxic and Immunosuppressive Drugs, Biologics, and Others), Mode of Delivery (Intravenous, Subcutaneous, Oral), and Region 2024-2032

  • Report
  • 142 Pages
  • Global
From
Anti-malarial Drugs Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2030 - Product Image

Anti-malarial Drugs Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2030

  • Report
  • 255 Pages
  • Global
From
Anti-Malarial Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Image

Anti-Malarial Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • 102 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.